Stock CNTB CONNECT BIOPHARMA HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Connect Biopharma Holdings Limited

Equities

CNTB

US2075231017

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
1.39 USD +2.96% Intraday chart for Connect Biopharma Holdings Limited -19.65% +17.80%
Apr. 17 Sector Update: Health Care Stocks Retreating Late Afternoon MT
Apr. 17 Sector Update: Health Care MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care Stocks Retreating Late Afternoon
MT
Sector Update: Health Care
MT
Connect Biopharma Terminates Agreement on Antiallergic Candidate With Pfizer
MT
HC Wainwright Adjusts Price Target on Connect Biopharma Holdings to $8 From $7, Maintains Buy Rating
MT
Connect Biopharma Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
GL
ADRs Advance, Eco Wave Power Global AB Climbs 213.4%
DJ
ADRs Advance; Connect Biopharma Climbs 19%
DJ
ADRs Close Lower; Moatable Inc. Declines 33.3%
DJ
ADRs End Higher; Connect Biopharma Climbs 26%
DJ
ADRs End Higher; Connect Biopharma Holdings Climbs 21%
DJ
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
GL
HC Wainwright Starts Coverage on Connect Biopharma With Buy Rating, $7 Price Target
MT
ADRs End Flat; Tuniu Climbs 16%
DJ
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
GL
Connect Biopharma Holdings Limited Appoints James Huang to Board of Directors
CI
ADRs End With Gains; TC BioPharm Climbs 38%
DJ
Transcript : Connect Biopharma Holdings Limited - Special Call
Connect Biopharma Holdings Limited Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-To-Severe Persistent Asthma
CI
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CNTB Stock
  4. News Connect Biopharma Holdings Limited